Ushbu ish iqtibos qilgan ishlar
335 ta ish
Ish: CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek, Krzysztof Chylinski, Ines Fonfara +3
MaqolaOchiq kirish20129 iqtibosABIParkinson's disease
Bastiaan R. Bloem, Michael S. Okun, Christine Klein
Sharh maqolaOchiq kirish20217 iqtibosABIRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi, Matthew H. Larson, Luke A. Gilbert +4
MaqolaOchiq kirish20135 iqtibosABIDelivering CRISPR: a review of the challenges and approaches
Christopher A. Lino, Jason C. Harper, James P. Carney +1
Sharh maqolaOchiq kirish20185 iqtibosABIMultiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong, F. Ann Ran, David Cox +8
MaqolaOchiq kirish20134 iqtibosABICRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau +5
Maqola20074 iqtibosABIOne-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang, Hui Yang, Chikdu Shivalila +4
MaqolaOchiq kirish20134 iqtibosABIEvolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Kira S. Makarova, Yuri I. Wolf, Jaime Iranzo +23
Sharh maqolaOchiq kirish20194 iqtibosABIGenome engineering using the CRISPR-Cas9 system
F. Ann Ran, Patrick D. Hsu, Jason Wright +3
MaqolaOchiq kirish20133 iqtibosABI53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
Sharh maqolaOchiq kirish20143 iqtibosABIPhenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy, Mario Falchi, Sean S. O’Sullivan +22
MaqolaOchiq kirish20083 iqtibosABIThe Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
Sharh maqolaOchiq kirish20103 iqtibosABIApplications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li, Yang Yang, Weiqi Hong +3
Sharh maqolaOchiq kirish20203 iqtibosABIDNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu, David A. Scott, Joshua A. Weinstein +11
MaqolaOchiq kirish20132 iqtibosABICRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza Deltcheva, Krzysztof Chylinski, Cynthia M. Sharma +6
MaqolaOchiq kirish20112 iqtibosABIMeasuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
Taeyoung Koo, Jungjoon Lee, Jin‐Soo Kim
Sharh maqolaOchiq kirish20152 iqtibosABIEffect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya +17
MaqolaOchiq kirish20132 iqtibosABIRNA-Guided Human Genome Engineering via Cas9
Prashant Mali, Luhan Yang, Kevin M. Esvelt +5
MaqolaOchiq kirish20132 iqtibosABIHigh-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu, Jennifer A Foden, Cyd Khayter +4
MaqolaOchiq kirish20132 iqtibosABI